To Cover Debts, Synergy Inks $200M Bankruptcy Sale to Bausch Health

To Cover Debts, Synergy Inks $200M Bankruptcy Sale to Bausch Health

Source: 
Xconomy
snippet: 

Synergy Pharmaceuticals has spent years looking for a buyer. The developer of a struggling drug for two types of chronic constipation finally has one—now that it’s gone bankrupt.